)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Getinge
Getinge (GETI) investor relations material
Getinge Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary21 Oct, 2026
Executive summary
Q3 organic net sales grew 2.1% and order intake 2.6%; adjusted EBITA margin rose 2.0 percentage points to 15.1%.
Free cash flow reached SEK 1,302M, up from SEK 793M YoY; customer satisfaction and employee engagement reached all-time highs.
YTD organic growth was 2.5%; FY26 guidance remained 3%–5%, adjusted for the Surgical Perfusion phase-out.
Financial highlights
Net sales were SEK 8,446M, up from SEK 8,226M YoY, with 2.1% organic growth.
Adjusted gross profit rose 7.2% to SEK 4,343M; adjusted gross margin increased to 51.4% from 49.2%.
Adjusted EBITA was SEK 1,278M, up 18.4% YoY; margin was 15.1% versus 13.1%.
Q3 adjusted EBITA included SEK 45M in tariff refunds and ~SEK 36M in favorable currency effects; excluding both, margin improved to 14.3%.
Free cash flow was SEK 1,302M; improved operating profit and working-capital changes supported cash generation.
Outlook and guidance
FY26 organic net sales growth guidance remained 3%–5%, adjusted for the Surgical Perfusion phase-out, despite YTD growth of 2.5%.
Surgical Perfusion sales in 2026 are expected to decline from ~SEK 250M to SEK 50M.
The adjusted EBITA margin target remains 16%–19% by end-2028; levers include quality-cost reductions, recurring and high-margin mix, productivity and product launches.
Q4 is typically the largest sales quarter, with capital-goods sales weighted toward year-end.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Getinge
- A 15% annual growth ambition pairs acquisitions with organic growth and supply-chain gains.GETI
CMD 2006 presentation - Growth and margin ambitions center on international reach, supply-chain gains and Huntleigh integration.GETICMD 2007 presentation
- Cash flow improved, but acquisition funding lifted net debt to MSEK 10,365.GETICMD 2008 presentation
- Datascope deal adds cardiovascular scale, with earnings accretion expected by 2010.GETIAcquisition presentation
- EBITA rose 33.5% as margins strengthened; Huntleigh integration and the 2007 outlook remained on plan.GETIQ1 2007
- Q2 adjusted EBITA rose 40.9% as sales grew 28%, with favourable 2007 guidance.GETIQ2 2007
- Q3 adjusted EBITA rose 33% as strong orders offset Huntleigh integration costs.GETIQ3 2007
- Sales grew 26.5%; Boston acquisition and margin targets set the next growth phase.GETIQ4 2007
- FY08 earnings climbed as Q4 organic orders grew 5.1%; FY09 adjusted EBITA target is 18–19%.GETIQ4 2008
- Sales rose, but recession restrained organic growth as Datascope reshaped results.GETIQ1 2009
Next Getinge earnings date
Q4 202626 Jan, 2027
Getinge
Next Getinge earnings date
Q4 202626 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Getinge is a global medical technology company that offers products and solutions for operating rooms, intensive-care units, and sterilization departments. These are used for a wide range of surgeries, for patient treatment in critical conditions, and for sterilizing tools to be used in surgical procedures. Getinge offers one of the broadest portfolios in the industry, designed to meet the demands of complex and highly specialized healthcare environments. Getinge was founded in 1904 and is headquartered in Gothenburg, Sweden.